Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: RETRACTED ARTICLE: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395

Fig. 5

HnRNP A1 is an oncogene in ccRCC. a The proliferative ability was assessed by colony formation assays in 786-O and OS-RC-2 cells expressing HnRNP A1 or sh-HnRNP A1. b EdU incorporation assays were conducted to acquire the percent of proliferating cells in HnRNP A1 overexpressed or sh-HnRNP A1 silenced 786-O and OS-RC-2 cells. c The cell viability was determined by MTS assays in 786-O and OS-RC-2 cells expressing HnRNP A1 or sh-HnRNP A1. d-e 786-O and OS-RC-2 cells with HnRNP A1 overexpression or HnRNP A1 knockdown were subjected to Transwell migration and invasion assay

Back to article page